EDMONTON, Alberta--(BUSINESS WIRE)--Nov. 15, 2005--ViRexx Medical Corp. (TSX:VIR) a company focused on immunotherapy treatments for certain cancers, chronic hepatitis B & C and embolotherapy treatments for tumors, today announced that Marc Canton, President and Chief Operating Officer of ViRexx, is scheduled to present at the upcoming Technology Finance Conference 2005 in Milan, Italy. The presentation is scheduled for 11:20 a.m. (local time) on Thursday, November 17, 2005. The Technology Finance Conference will be held from November 17-18, 2005 at the Jolly Hotel President in Milan.
